PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows

NCT07387510 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Patients Undergoing Radical Prostatectomy

Interventions

DRUG: 12 h before RP
DRUG: 24 h before RP
DRUG: 36 h before RP

Sponsor

Haitao Niu, MD